Core Scientific Bundle
Who Really Owns Core Scientific?
In the fast-paced world of digital assets and high-performance computing, understanding the ownership of a company like Core Scientific is critical. Its journey through Chapter 11 bankruptcy in January 2024 fundamentally reshaped its ownership structure, setting the stage for a new chapter. This analysis explores the intricate details of Core Scientific's ownership.
Core Scientific (NASDAQ: CORZ), a leading provider of blockchain infrastructure and software solutions, emerged from bankruptcy with a renewed focus on growth. With a reported revenue of $502.2 million in 2024 and a market capitalization of $3.54 billion as of June 13, 2025, understanding the Core Scientific SWOT Analysis is essential. This exploration will examine the evolution of Core Scientific ownership, including its major shareholders, and how these shifts have influenced its trajectory, including its Core Scientific stock.
Who Founded Core Scientific?
The initial formation of Core Scientific in 2017 involved several key individuals. Tarik K. Musaddiq, Russell Cann, and Zachary Schreiber are listed as the founding team members. Aber Whitcomb and Darin Feinstein are also recognized as co-founders.
Early financial backing was crucial for Core Scientific's operations. The company secured an initial funding round of $54 million in 2017. This round was led by GIC Pte, a Singapore-based investment firm.
Core Scientific has experienced multiple funding rounds over time. The company has raised a total of $49 million across seven funding rounds, including seed, early-stage, and post-IPO rounds. This demonstrates the evolving Core Scientific ownership structure and investor confidence.
The company's financial journey has been marked by significant investment rounds. These investments have played a key role in shaping the Core Scientific stock trajectory. The company's ability to attract investment is a key factor in its Core Scientific financials.
- In January 2023, a post-IPO round secured $500 million.
- An August 2024 round brought in $400 million.
- Early agreements and specific equity splits for the founders are not publicly detailed in the provided information.
- Understanding the evolution of Core Scientific investors is crucial for assessing its financial health.
Core Scientific SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Core Scientific’s Ownership Changed Over Time?
The evolution of Core Scientific's ownership has been marked by significant events. Initially, the company went public in January 2022 through a merger with Power & Digital Infrastructure Acquisition Corp. (XPDI), a special purpose acquisition company (SPAC). Following this transaction, former Core Scientific stockholders held a substantial 90.7% of the common stock. The company's stock began trading on the Nasdaq Stock Market under the symbols 'CORZ' and 'CORZW'.
A major shift occurred when the company faced financial challenges. Rising energy costs and declining cryptocurrency prices in 2022 led to restructuring efforts. This culminated in the company emerging from bankruptcy in January 2024. The restructuring included a reduction of $400 million in debt through the conversion of debt to equity. This significantly altered the ownership structure, with creditors and equipment lenders receiving equity in the reorganized company. As of April 2025, the company is publicly traded, with shares available to the general public, and the ownership is a mix of institutional investors, insiders, and retail investors.
| Ownership Category | Approximate Percentage (April 2025) | Notes |
|---|---|---|
| Institutional Investors | Approximately 47.06% | Major holders include Vanguard Group Inc and BlackRock, Inc. |
| Insiders | 3.25% | Includes company executives and board members. |
| Public Companies and Individual Investors | 17.16% | Represents shares held by the general public. |
As of November 2024, BlackRock, Inc. held 15,547,691 shares, representing 6.0% ownership. Ibex Investor, as of January 2024, beneficially owned 11.38 million shares, accounting for a 6% stake after the company's emergence from Chapter 11. The company's market capitalization increased by 280.84% in one year, reaching $3.54 billion as of June 13, 2025. This data indicates the influence of institutional investors on the Core Scientific ownership structure, as well as the impact of the Core Scientific bankruptcy and subsequent restructuring on the company's financial landscape and Core Scientific investors.
The ownership of Core Scientific is primarily composed of institutional investors, insiders, and public shareholders.
- Institutional investors hold a significant portion of the company's stock.
- The company's restructuring and emergence from bankruptcy in January 2024 significantly impacted its ownership structure.
- The market capitalization has seen substantial growth, reflecting changes in the Core Scientific financials.
- The company's stock symbol is CORZ.
Core Scientific PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Core Scientific’s Board?
Following its emergence from Chapter 11 bankruptcy in January 2024, Core Scientific announced a new Board of Directors. However, the specific composition of the board, including the representation of major shareholders, founders, or independent seats, is not fully detailed in the available information. Further details regarding the board members and their affiliations would provide a clearer picture of the company's governance structure.
As a publicly traded company, Core Scientific's governance is influenced by its board of directors. The standard voting structure for publicly traded companies is typically one-share-one-vote. The influence of major institutional investors, who collectively hold a significant portion of the shares, suggests a substantial role in company governance. The exact voting power distribution among these investors is not specified in the provided data.
| Board Member | Title | Notes |
|---|---|---|
| Adam Sullivan | Chairman of the Board | Appointed January 2024 |
| Michael Brosseau | Director | Appointed January 2024 |
| Matthew K. O'Rourke | Director | Appointed January 2024 |
The voting structure, typical for a publicly traded company, is generally one-share-one-vote. The influence of major institutional investors, holding a significant portion of shares, is substantial. Details about recent proxy battles or governance controversies are not available. The company's financial performance and stock price history are key factors for investors. Understanding the Core Scientific ownership structure, including Core Scientific investors and the Core Scientific stock dynamics, is crucial for anyone looking to invest or understand the company's operations.
Core Scientific emerged from bankruptcy in January 2024 with a new Board of Directors. The board's composition and the influence of major shareholders are key to understanding the company's governance. The standard one-share-one-vote structure applies, with institutional investors holding a significant portion of shares.
- The board of directors was restructured after the bankruptcy.
- Institutional investors have a significant impact on voting power.
- The company operates under a standard one-share-one-vote system.
- Further details on board member affiliations would be beneficial.
Core Scientific Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Core Scientific’s Ownership Landscape?
In the past few years, Core Scientific has seen significant shifts in its ownership and strategic direction. A major turning point was its emergence from Chapter 11 bankruptcy in January 2024, which involved converting $400 million in debt to equity. This restructuring was critical for the company's ongoing operations and future growth.
A key strategic move for Core Scientific has been its focus on high-density AI-focused data center infrastructure, expanding beyond just Bitcoin mining. In February 2025, the company partnered with AI startup CoreWeave for a $1.2 billion data center expansion. This deal is a capital-light, take-or-pay agreement, with CoreWeave pre-funding development costs in most cases. Core Scientific aims to provide 250 megawatts of billable capacity to CoreWeave by the end of 2025 and 590 megawatts by early 2027, with the total projected revenue from this partnership reaching $10.2 billion over a 12-year contract.
| Metric | Value | Date |
|---|---|---|
| Institutional Owners | 567 | May 2025 |
| Total Shares Held by Institutions | 262,464,107 | May 2025 |
| Market Capitalization | $3.54 billion | June 13, 2025 |
| Total Revenue (Q1 2025) | $79.5 million | Q1 2025 |
Institutional ownership remains a significant factor in Core Scientific's ownership structure. As of May 2025, there are 567 institutional owners holding a total of 262,464,107 shares. Notable increases in holdings have been seen from firms like Fred Alger Management LLC and Clearline Capital LP. Additionally, recent insider trading activity indicates purchases by company executives and board members. To better understand the company's target market, consider reading this article: Target Market of Core Scientific.
The company emerged from Chapter 11 bankruptcy in January 2024, a crucial step in its financial restructuring. This process involved converting a significant amount of debt into equity, which allowed Core Scientific to continue its operations.
Institutional ownership is a key aspect of Core Scientific's stock. As of May 2025, a large number of institutional investors hold a substantial number of shares. Recent filings show increased holdings by several firms.
The company's financial performance for the first quarter of 2025 showed a total revenue of $79.5 million and a net income of $580.7 million. Core Scientific holds approximately 3,000 Bitcoins as of early 2025, valued at around $200 million.
The partnership with CoreWeave for data center expansion marks a significant strategic shift. This deal is expected to generate substantial revenue over the next 12 years, with a focus on AI-related infrastructure.
Core Scientific Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What are Mission Vision & Core Values of Core Scientific Company?
- What is Competitive Landscape of Core Scientific Company?
- What is Growth Strategy and Future Prospects of Core Scientific Company?
- How Does Core Scientific Company Work?
- What is Sales and Marketing Strategy of Core Scientific Company?
- What is Brief History of Core Scientific Company?
- What is Customer Demographics and Target Market of Core Scientific Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.